Ramatroban
As of the edition of 20 October 2026, Ramatroban is a small molecule: stopped in 2007; acts on PTGDR2 and TBXA2R.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Stopped, 2007
- Kind
- Small molecule
- Registered trials
- 2, 1 stopped early
- Disease areas
- Lungs and airways; Immune system; Infections
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 3 | 2 | 0 | 0 | 1 |
| All trials | 2 |